Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #201 to #250.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) ‎[449 bytes]
  2. (hist) ‎Da'Ron Payne 1 Yd pass from Jalen Hurts (Andy Pappanastos Kick) (1/1/18) ‎[344 bytes]
  3. (hist) ‎Financial support (from DOI: 10.1016/j.clim.2020.108427) ‎[332 bytes]
  4. (hist) ‎National Health Commission cited as Ref 1 in DOI: 10.1080/22221751.2020.1735265 ‎[328 bytes]
  5. (hist) ‎Hemming VG., et al, Clin Diagn Lab Immunol (2001) cited as Ref 7 in DOI: 10.1080/22221751.2020.1735265 ‎[328 bytes]
  6. (hist) ‎Mori I, et al, PLoS One (2008) cited as Ref 6 in DOI: 10.1080/22221751.2020.1735265 ‎[328 bytes]
  7. (hist) ‎Taoran G, et al, Chin J Internal Med (2020) cited as Ref 5 in DOI: 10.1080/22221751.2020.1735265 ‎[328 bytes]
  8. (hist) ‎Tai-sheng LI, et al, Chin J Lab Med (2003) cited as Ref 4 in DOI: 10.1080/22221751.2020.1735265 ‎[328 bytes]
  9. (hist) ‎Li T, et al, Chin Med J (Engl) (2003) cited as Ref 3 in DOI: 10.1080/22221751.2020.1735265 ‎[328 bytes]
  10. (hist) ‎World Health Organization cited as Ref 2 in DOI: 10.1080/22221751.2020.1735265 ‎[328 bytes]
  11. (hist) ‎References (from DOI:10.14218/ERHM.2020.00023) ‎[325 bytes]
  12. (hist) ‎Declaration of Competing Interest (from DOI: 10.1016/j.jcv.2020.104372) ‎[324 bytes]
  13. (hist) ‎Section 2: Is SARS-CoV-2 a congenital or perinatally-acquired pathogen for the neonate? (from DOI: 10.1016/j.jcv.2020.104372) ‎[321 bytes]
  14. (hist) ‎Tua Tagovailoa pass complete to DeVonta Smith for 27 yds for a TD (Andy Pappanastos KICK) (9/23/17) ‎[317 bytes]
  15. (hist) ‎Funding (from DOI: 10.1016/j.jcv.2020.104372) ‎[315 bytes]
  16. (hist) ‎Conflicts of Interest (from DOI: 10.3390/v12020211) ‎[312 bytes]
  17. (hist) ‎Funding (from DOI: 10.3390/v12020211) ‎[311 bytes]
  18. (hist) ‎Ethics approval and consent to participate (from DOI: 10.1186/s13054-020-02882-x) ‎[304 bytes]
  19. (hist) ‎References (from DOI: 10.1007/s11886-020-01292-3) ‎[304 bytes]
  20. (hist) ‎Competing interests (from DOI: 10.1038/s41392-020-0110-5) ‎[304 bytes]
  21. (hist) ‎Reference 1 in the bibliography for DOI: 10.7326/m20-0504 ‎[303 bytes]
  22. (hist) ‎Availability of data and materials (from DOI: 10.1186/s13054-020-02882-x) ‎[296 bytes]
  23. (hist) ‎Consent for publication (from DOI: 10.1186/s13054-020-02882-x) ‎[285 bytes]
  24. (hist) ‎References (from DOI: 10.1007/s11886-020-01293-2) ‎[285 bytes]
  25. (hist) ‎Player Indexing ‎[284 bytes]
  26. (hist) ‎Reference section from DOI: 10.3201/eid2605.200146 ‎[278 bytes]
  27. (hist) ‎References (from DOI: 10.1084/jem.20200653) ‎[276 bytes]
  28. (hist) ‎Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[275 bytes]
  29. (hist) ‎Competing interests (from DOI: 10.1186/s13054-020-02882-x) ‎[271 bytes]
  30. (hist) ‎CDC, (2020), cited as Ref 22 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  31. (hist) ‎Shi S, et al, JAMA Cardiol (2020), cited as Ref 21 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  32. (hist) ‎Li Q, et al, N Engl J Med (2020), cited as Ref 20 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  33. (hist) ‎Nextrain.org, (2020), cited as Ref 19 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  34. (hist) ‎European CDC (2020), cited as Ref 18 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  35. (hist) ‎McIntosh K, et al, Uptodate (2020), cited as Ref 17 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  36. (hist) ‎WHO, (2020), cited as Ref 16 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  37. (hist) ‎CDC, (2020), cited as Ref 15 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  38. (hist) ‎Buchanan L, et al, New York Times (2020), cited as Ref 14 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  39. (hist) ‎Ritchie H, et al, Coronavirus Source Data, (2020), cited as Ref 13 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  40. (hist) ‎Ginsberg J, et al, Nature (2009), cited as Ref 12 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  41. (hist) ‎Wilson N, et al, Euro Surveill (2009), cited as Ref 11 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  42. (hist) ‎Ayyoubzadeh SMo, et al, JMIR Public Health Surveill (2020), cited as Ref 10 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  43. (hist) ‎Husnayain A, et al, Int J Infect Dis (2020), cited as Ref 9 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  44. (hist) ‎Mavragani A, et al, JMIR Public Health Surveill (2020), cited as Ref 8 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  45. (hist) ‎Li C, et al, Euro Surveill (2020), cited as Ref 7 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  46. (hist) ‎Wu JT, et al, Lancet (2020), cited as Ref 6 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  47. (hist) ‎1Point3Acres, et al, (2020), cited as Ref 5 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  48. (hist) ‎Zhang L, et al, Explor Res Hypothesis Med (2020), cited as Ref 4 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  49. (hist) ‎Dong E, et al, Lancet Infect Dis (2020), cited as Ref 3 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]
  50. (hist) ‎WHO, (2020), cited as Ref 2 in DOI:10.14218/ERHM.2020.00023 ‎[270 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:LongPages"